Joseph Levine

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Co-author Network

Publications

TOP 3
A Bromberg; Y Bersudsky; J Levine; G Agam
Global leukocyte DNA methylation is not altered in euthymic bipolar patients.
Joseph Levine; Zeev Kaplan; Jay W Pettegrew; Richard J McClure; Samuel Gershon; Igor Buriakovsky; Hagit Cohen
Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats.
N R Chengappa; Haranath Parepally; Jaspreet S Brar; Aziz Gopalani; Lokaranjit Chalasani; Jonathan Bear; Joseph Levine
Attitudes towards taking Medicine among those patients who either received Olanzapine or First Generation Antipsychotic Agents.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Joseph Levine (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2009: A Bromberg; Y Bersudsky; J Levine; G Agam
Global leukocyte DNA methylation is not altered in euthymic bipolar patients.
Journal of affective disorders 2009;118(1-3):234-9.
2005: Joseph Levine; Zeev Kaplan; Jay W Pettegrew; Richard J McClure; Samuel Gershon; Igor Buriakovsky; Hagit Cohen
Effect of intraperitoneal acetyl-L-carnitine (ALCAR) on anxiety-like behaviours in rats.
The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP) 2005;8(1):65-74.
2003: N R Chengappa; Haranath Parepally; Jaspreet S Brar; Aziz Gopalani; Lokaranjit Chalasani; Jonathan Bear; Joseph Levine
Attitudes towards taking Medicine among those patients who either received Olanzapine or First Generation Antipsychotic Agents.
Indian journal of psychiatry 2003;45(3):151-4.
2003: J Levine; K Panchalingam; R J McClure; S Gershon; J W Pettegrew
Effects of acetyl-L-carnitine and myo-inositol on high-energy phosphate and membrane phospholipid metabolism in zebra fish: a 31P-NMR-spectroscopy study.
Neurochemical research 2003;28(5):687-90.
2003: K N Roy Chengappa; Jeffrey M Goldstein; Mike Greenwood; Vineeth John; Joseph Levine
A post hoc analysis of the impact on hostility and agitation of quetiapine and haloperidol among patients with schizophrenia.
Clinical therapeutics 2003;25(2):530-41.
2002: K N Roy Chengappa; L Chalasani; Jaspreet S Brar; H Parepally; Patricia Houck; Joseph Levine
Changes in body weight and body mass index among psychiatric patients receiving lithium, valproate, or topiramate: an open-label, nonrandomized chart review.
Clinical therapeutics 2002;24(10):1576-84.
2002: Haranath Parepally; Sudeep Chakravorty; Joseph Levine; Jaspreet S Brar; Amit M Patel; James W Baird; Lokaranjit Chalasani; Joyce A Delaney; Rebecca Atzert; K N Roy Chengappa
The use of concomitant medications in psychiatric inpatients treated with either olanzapine or other antipsychotic agents: a naturalistic study at a state psychiatric hospital.
Progress in neuro-psychopharmacology & biological psychiatry 2002;26(3):437-40.
2002: Jay W Pettegrew; Joseph Levine; Samuel Gershon; Jeffrey A Stanley; David Servan-Schreiber; Kanagasabai Panchalingam; Richard J McClure
31P-MRS study of acetyl-L-carnitine treatment in geriatric depression: preliminary results.
Bipolar disorders 2002;4(1):61-6.
2002: K N R Chengappa; J Vasile; J Levine; R Ulrich; R Baker; A Gopalani; N Schooler
Clozapine: its impact on aggressive behavior among patients in a state psychiatric hospital.
Schizophrenia research 2002;53(1-2):1-6.
2001: J Levine; K N Chengappa; A Patel; A Vagnucci; V John; J S Brar; L Chalasani; H Parepally; R Ganguli
Obesity and medical illnesses in psychiatric patients admitted to a long-term psychiatric facility.
Journal of psychiatric practice 2001;7(6):432-9.
2001: J Levine; U Leventhal; V Lerner; R H Belmaker
Inositol treatment has no effect on the dexamethasone suppression test.
The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry 2001;2(4):190-2.
2001: K N Chengappa; S Gershon; J Levine
The evolving role of topiramate among other mood stabilizers in the management of bipolar disorder.
Bipolar disorders 2001;3(5):215-32.
2001: J W Pettegrew; K Panchalingam; R J McClure; S Gershon; L R Muenz; J Levine
Effects of chronic lithium administration on rat brain phosphatidylinositol cycle constituents, membrane phospholipids and amino acids.
Bipolar disorders 2001;3(4):189-201.
2001: K N Chengappa; R K Kambhampati; K Perkins; R Nigam; T Anderson; J S Brar; H K Vemulapalli; R Atzert; P Key; J S Kang; et al.
Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.
The Journal of clinical psychiatry 2001;62(7):503-8.
2001: K N Roy Chengappa; J Levine; D Rathore; H Parepally; R Atzert
Long-term effects of topiramate on bipolar mood instability, weight change and glycemic control: a case-series.
European psychiatry : the journal of the Association of European Psychiatrists 2001;16(3):186-90.
2001: D Gelber; J Levine; R H Belmaker
Effect of inositol on bulimia nervosa and binge eating.
The International journal of eating disorders 2001;29(3):345-8.
2001: J W Pettegrew; K Panchalingam; J Levine; R J McClure; S Gershon; J K Yao
Chronic myo-inositol increases rat brain phosphatidylethanolamine plasmalogen.
Biological psychiatry 2001;49(5):444-53.
2001: J W Pettegrew; K Panchalingam; R J McClure; J Levine
Brain metabolic effects of acute nicotine.
Neurochemical research 2001;26(2):181-5.
2001: J Levine; K N Chengappa; J S Brar; S Gershon; D J Kupfer
Illness characteristics and their association with prescription patterns for bipolar I disorder.
Bipolar disorders 2001;3(1):41-9.
2000: K N Chengappa; M Tohen; J Levine; T Jacobs; M E Thase; T M Sanger; D J Kupfer
Response to placebo among bipolar I disorder patients experiencing their first manic episode.
Bipolar disorders 2000;2(4):332-5.
2000: K N Chengappa; J Levine; R Ulrich; H Parepally; J S Brar; R Atzert; R Brienzo; A Gopalani
Impact of risperidone on seclusion and restraint at a state psychiatric hospital.
Canadian journal of psychiatry. Revue canadienne de psychiatrie 2000;45(9):827-32.
2000: J W Pettegrew; J Levine; R J McClure
Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer's disease and geriatric depression.
Molecular psychiatry 2000;5(6):616-32.
2000: K N Chengappa; J Levine; S Gershon; D J Kupfer
Lifetime prevalence of substance or alcohol abuse and dependence among subjects with bipolar I and II disorders in a voluntary registry.
Bipolar disorders 2000;2(3 Pt 1):191-5.
2000: J Levine; K N Chengappa; H Parepally
Side effect profile of enteric-coated divalproex sodium versus valproic acid.
The Journal of clinical psychiatry 2000;61(9):680-1.
2000: S M Antelman; J Levine; S Gershon
Time-dependent sensitization: the odyssey of a scientific heresy from the laboratory to the door of the clinic.
Molecular psychiatry 2000;5(4):350-6.
2000: J Levine; K N Chengappa; J S Brar; S Gershon; E Yablonsky; D Stapf; D J Kupfer
Psychotropic drug prescription patterns among patients with bipolar I disorder.
Bipolar disorders 2000;2(2):120-30.
2000: K N Chengappa; B G Pollock; H Parepally; J Levine; M A Kirshner; J S Brar; R A Zoretich
Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine.
Journal of clinical psychopharmacology 2000;20(3):311-6.
2000: J Levine; K Panchalingam; A Rapoport; S Gershon; R J McClure; J W Pettegrew
Increased cerebrospinal fluid glutamine levels in depressed patients.
Biological psychiatry 2000;47(7):586-93.
2000: K N Chengappa; J Levine; S Gershon; A G Mallinger; A Hardan; A Vagnucci; B Pollock; J Luther; J Buttenfield; S Verfaille; et al.
Inositol as an add-on treatment for bipolar depression.
Bipolar disorders 2000;2(1):47-55.
2000: J Levine; K Panchalingam; McClure RJ2; S Gershon; J W Pettegrew
Stability of CSF metabolites measured by proton NMR.
Journal of neural transmission (Vienna, Austria : 1996) 2000;107(7):843-8.
1999: K N Chengappa; D Rathore; J Levine; R Atzert; L Solai; H Parepally; H Levin; N Moffa; J Delaney; J S Brar
Topiramate as add-on treatment for patients with bipolar mania.
Bipolar disorders 1999;1(1):42-53.
1999: K N Chengappa; T Ebeling; J S Kang; J Levine; H Parepally
Clozapine reduces severe self-mutilation and aggression in psychotic patients with borderline personality disorder.
The Journal of clinical psychiatry 1999;60(7):477-84.
1999: S M Antelman; J Levine; S Gershon; A R Caggiula
Pills or placebos?
Science (New York, N.Y.) 1999;284(5416):913-4.
1999: J Levine; A Mishori; M Susnosky; M Martin; R H Belmaker
Combination of inositol and serotonin reuptake inhibitors in the treatment of depression.
Biological psychiatry 1999;45(3):270-3.
1999: B Nemets; A Mishory; J Levine; R H Belmaker
Inositol addition does not improve depression in SSRI treatment failures.
Journal of neural transmission (Vienna, Austria : 1996) 1999;106(7-8):795-8.
1998: H Einat; J Levine; E Grauer; K MacDonald; R H Belmaker
Effect of inositol treatment on the behavior of rhesus monkeys: preliminary results.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(6):999-1005.
1998: V Gavrilov; J Levine; G Agam; R H Belmaker
Lithium enhancement of the prolactin response to 5-hydroxytryptophan is not reversible by inositol.
Progress in neuro-psychopharmacology & biological psychiatry 1998;22(3):523-8.
1997: J Levine
Controlled trials of inositol in psychiatry.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1997;7(2):147-55.
1997: J Levine; A Aviram; A Holan; A Ring; Y Barak; R H Belmaker
Inositol treatment of autism.
Journal of neural transmission (Vienna, Austria : 1996) 1997;104(2-3):307-10.
1996: M Fux; J Levine; A Aviv; R H Belmaker
Inositol treatment of obsessive-compulsive disorder.
The American journal of psychiatry 1996;153(9):1219-21.
1996: Y Barak; J Levine; A Glasman; A Elizur; R H Belmaker
Inositol treatment of Alzheimer's disease: a double blind, cross-over placebo controlled trial.
Progress in neuro-psychopharmacology & biological psychiatry 1996;20(4):729-35.
1996: J Levine; L Kurtzman; A Rapoport; J Zimmerman; Y Bersudsky; J Shapiro; R H Belmaker; G Agam
CSF inositol does not predict antidepressant response to inositol. Short communication.
Journal of neural transmission (Vienna, Austria : 1996) 1996;103(12):1457-62.
1996: R H Belmaker; Y Bersudsky; G Agam; J Levine; O Kofman
How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory.
Annual review of medicine 1996;47():47-56.
1995: J Levine; T Pomerantz; S Stier; R H Belmaker
Lack of effect of 6 g inositol treatment of post-ECT cognitive function in humans.
Journal of psychiatric research 1995;29(6):487-9.
1995: J Benjamin; J Levine; M Fux; A Aviv; D Levy; R H Belmaker
Double-blind, placebo-controlled, crossover trial of inositol treatment for panic disorder.
The American journal of psychiatry 1995;152(7):1084-6.
1995: J Benjamin; G Agam; J Levine; Y Bersudsky; O Kofman; R H Belmaker
Inositol treatment in psychiatry.
Psychopharmacology bulletin 1995;31(1):167-75.
1995: R H Belmaker; Y Bersudsky; J Benjamin; G Agam; J Levine; O Kofman
Manipulation of inositol-linked second messenger systems as a therapeutic strategy in psychiatry.
Advances in biochemical psychopharmacology 1995;49():67-84.
1995: J Levine; Y Barak; O Kofman; R H Belmaker
Follow-up and relapse analysis of an inositol study of depression.
The Israel journal of psychiatry and related sciences 1995;32(1):14-21.
1994: J Levine; I Goldberger; A Rapaport; M Schwartz; C Schield; A Elizur; R H Belmaker; J Shapiro; G Agam
CSF inositol in schizophrenia and high-dose inositol treatment of schizophrenia.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1994;4(4):487-90.
1993: J Levine; A Rapaport; L Lev; Y Bersudsky; O Kofman; R H Belmaker; J Shapiro; G Agam
Inositol treatment raises CSF inositol levels.
Brain research 1993;627(1):168-70.